After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
HIMS belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Hims & Hers Health Inc is $8.91B. A total of 9.51 million shares were traded on the day, compared to an average of 27.42M shares.
In the most recent transaction, Boughton Soleil sold 2,631 shares of HIMS for 35.22 per share on Nov 24 ’25. After the transaction, the Chief Legal Officer now owns 153,225 company shares. In a previous transaction on Nov 24 ’25, Boughton Soleil bought 2,631 shares at 35.11 per share.
Among the insiders who sold shares, Okupe Oluyemi disposed of 23,187 shares on Nov 17 ’25 at a per-share price of $36.81. This resulted in the Chief Financial Officer holding 70,232 shares of HIMS after the transaction. In another insider transaction, Boughton Soleil sold 2,637 shares at $42.53 per share on Nov 10 ’25. Company shares held by the Chief Legal Officer now total 155,856.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, HIMS has a high of $72.98 and a low of $23.97.
As of this writing, HIMS has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $0.15 per share and a lower estimate of -$0.04. The company reported an EPS of $0.11 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. HIMS’s latest balance sheet shows that the firm has $247.27M in Cash & Short Term Investments as of fiscal 2021. There were $5.48M in debt and $79.22M in liabilities at the time. Its Book Value Per Share was $2.55, while its Total Shareholder’s Equity was $334.62M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HIMS is Buy with a score of 3.23.
